| 查看: 908 | 回复: 6 | |||||||||
[交流]
【2014-10-31】Pulsus出版集团当代医学论坛 & 征稿(通知)
|
|||||||||
Call for Papers Current Oncology (www.current-oncology.com) Current Oncology is a peer-reviewed, Canadian based and internationally respected journal, indexed by Science Citation Index (SCI) with an Impact Factor (IF) of 1.473 (2013 Journal Citation Reports, Science Edition). Published bi-monthly, plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. The journal publishes a range of article types that encompass all aspects of cancer medicine: Original articles, Review articles, Commentaries, Practice guidelines, Letters to the Editor Perspectives, Short communications and Case reports. Manuscripts must be solely the work of the author(s) stated, must not have been previously published elsewhere, and must not be under consideration by another journal. Articles published in the journal contain information that is relevant directly to clinical oncology practice, and have clear potential for application to the current or future practice of cancer medicine. Current Oncology aims to facilitate the communication from the laboratory to the bedside; contributing to cancer prevention, treatment, early detection, diagnosis, survivorship and rehabilitation. All papers should be written to be clearly understandable to the journal’s readers in a wide range of specialties. Submissions in the area of basic research are not accepted by the journal. In 2012, the journal had over 250 submissions and an article acceptance rate of 57%. Articles submitted to the journal undergo our rigorous peer review process and must be accepted prior to publication. For further information about our peer review policy, please visit https://www.current-oncology.com ... issions#PeerReview. Benefits of Publishing with Current Oncology include: • Articles are freely and permanently accessible online immediately upon publication 相关信息访问中文网站 “朋博学者网”通知 https://www.medicinepub.com/inde ... tid=3&id=22 [ Last edited by Paulwolf on 2014-11-19 at 05:50 ] |
» 猜你喜欢
售SCI-T0P文章,我:8O.5.5.1.O.54,科目齐全,可+急
已经有5人回复
售SCI一区T0P文章,我:8O.55.1.O.5.4,科目齐全,可+急
已经有4人回复
上海工程技术大学 激光智能制造课题组 2027级博士研究生招生
已经有6人回复
课题组招2027级博士 上海工程技术大学 激光智能制造方向
已经有6人回复
现代”学阀”该如何界定
已经有14人回复
求合成方法
已经有8人回复
师弟论文见刊大半年才想起来申请专利,还能抢救一下吗?
已经有4人回复
有机合成以后会不会被AI改变?做科研的虫友怎么看
已经有8人回复
我的奶奶
已经有3人回复
» 抢金币啦!回帖就可以得到:
坐标无锡,诚征女友
+3/973
2026年材料结构与力学性能国际会议(MSMP 2026
+1/951
2026年物理学、化学与数据分析国际会议 (PCDA 2026)
+1/912
2027年航天航空、材料与人工智能国际会议(AMAI 2027)
+1/876
2027年电气工程、自动化与应用工程国际会议(EEAE 2027)
+1/858
2027年生物医学、农业与可持续发展国际会议(BASD 2027)
+1/836
2027年计算机视觉、设计与非遗文化传播国际会议(CVDC 2027)
+1/811
石河子大学能源与材料学院李航副教授课题组招收硕、博士
+1/98
石河子大学能源与材料学院李航副教授课题组招收硕、博士
+1/87
澳门大学孙鹏展博士课题组招收全奖博士研究生1名
+2/74
韩国全北国立大学禽病研究所博士研究生招生简章
+2/48
废油资源化教育部工程中心 诚聘催化方向特聘研究员
+1/10
大湾区大学姚瑶课题组2027届博士生招生 (与中山大学联合培养)
+1/6
国家纳米科学中心孙向南课题组招收2027届硕士1名
+1/3
国家纳米科学中心孙向南课题组招收2027级硕士1名
+1/3
CAR表达怎么测?定点荧光标记蛋白让流式细胞检测更直接
+1/2
从靶点发现到机制验证,肿瘤免疫治疗研究为什么离不开高质量抗体?
+1/1
中山大学中山医学院(深圳校区)-肿瘤细胞生物课题组招收联培(客座)硕士/博士生
+1/1
Runninghub平台RH币算力币充值
+1/1
国家纳米科学中心孙向南课题组招收2027级硕士1名
+1/1
6楼2014-10-19 21:36:03
7楼2014-10-20 15:22:51
简单回复
nono20092楼
2014-10-19 21:25
回复
xmh880523(金币+1): 谢谢参与
·
yuguiyan3楼
2014-10-19 21:27
回复
xmh880523(金币+1): 谢谢参与
, [ 发自小木虫客户端 ]
dmbb4楼
2014-10-19 21:28
回复
xmh880523(金币+1): 谢谢参与
大内总管5楼
2014-10-19 21:33
回复
xmh880523(金币+1): 谢谢参与












回复此楼